Literature DB >> 1917616

Impact of dose in outcome of irradiation alone in carcinoma of the uterine cervix: analysis of two different methods.

C A Perez1, S Fox, M A Lockett, P W Grigsby, H M Camel, A Galakatos, M S Kao, J Williamson.   

Abstract

This is a retrospective analysis of 1211 patients with histologically proven invasive carcinoma of the uterine cervix with a minimum follow-up of 3 years treated with irradiation alone. The pelvic failure rates by stage were 9.6% for IB, 18.6% for IIA, 23% for IIB, 41% for III, and 75% for Stage IVA disease. External beam and intracavitary irradiation doses to point A and pelvic lymph nodes were calculated. In patients with Stage IB and IIA disease there was no significant correlation between doses to these points and pelvic tumor control. In Stage IIB doses of less than 6000 cGy to point A correlated with a high pelvic failure rate (8 of 12, 66.7%) in contrast to doses of 6000 to 9000 cGy (61 of 261, 23.4%) or higher than 9000 cGy (10 of 74, 13.5%) (p less than or equal to 0.01). In Stage III the pelvic failure rate with doses below 6000 cGy to point A was 72% (18 of 25) compared to 39% (71 of 180) for 6000 to 9000 cGy or 35% (27 of 77) with doses above 9000 cGy (p less than or equal to 0.01). TDF calculation of doses was carried out. In Stage IB and IIA there was no significant correlation between TDF to point A and probability of pelvic recurrence. In Stage IIB with TDF below 135, the pelvic recurrence rate was 41.6% (20 of 48) compared to 20% (61 of 305) with higher TDF (p less than or equal to 0.01). In Stage III the pelvic failure rate was 51% with TDF below 160 (70 of 136) in comparison with 29.5% (46 of 156) with higher TDF (p less than or equal to 0.01). Grade 2 sequelae of therapy were noted in about 10% of the patients and grade 3 in 4.7% of patients with Stage IB (18 of 384), 10.2% (12 of 128) with Stage IIA, 9.3% (33 of 353) with Stage IIB, and 8.2% (24 of 293) with Stage III disease. Doses from external beam and intracavitary irradiation to the rectum or the bladder neck were calculated. The actuarial incidence of major rectal or rectosigmoid sequelae was 2% to 4% with doses to the rectum of 6000 to 8000 cGy, 7% to 8% with 8000 to 9500 cGy, and 13% with doses higher than 9500 cGy (p less than or equal to 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1917616     DOI: 10.1016/0360-3016(91)90726-k

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Radiation-induced Proctitis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-02

Review 2.  Current status and perspectives of brachytherapy for cervical cancer.

Authors:  Takafumi Toita
Journal:  Int J Clin Oncol       Date:  2009-02-20       Impact factor: 3.402

Review 3.  A review of recent developments in image-guided radiation therapy in cervix cancer.

Authors:  Azmat H Sadozye; Nicholas Reed
Journal:  Curr Oncol Rep       Date:  2012-12       Impact factor: 5.075

4.  Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.

Authors:  Mostafa Atri; Zheng Zhang; Farrokh Dehdashti; Susanna I Lee; Shamshad Ali; Helga Marques; Wui-Jin Koh; Kathleen Moore; Lisa Landrum; Jae Weon Kim; Paul DiSilvestro; Eric Eisenhauer; Frederick Schnell; Michael Gold
Journal:  Gynecol Oncol       Date:  2016-07-27       Impact factor: 5.482

5.  Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities.

Authors:  Tanja Fehm; Frederik A Stübs; Martin C Koch; Peter Mallmann; Christian Dannecker; Anna Dietl; Anna Sevnina; Franziska Mergel; Laura Lotz; Anne Ehret; Daniel Gantert; Franca Martignoni; Jan-Philipp Cieslik; Jan Menke; Olaf Ortmann; Carmen Stromberger; Karin Oechsle; Beate Hornemann; Friederike Mumm; Christoph Grimm; Alina Sturdza; Edward Wight; Kristina Loessl; Michael Golatta; Volker Hagen; Timm Dauelsberg; Ingo Diel; Karsten Münstedt; Eberhard Merz; Dirk Vordermark; Katja Lindel; Christian Wittekind; Volkmar Küppers; Ralph Lellé; Klaus Neis; Henrik Griesser; Birgit Pöschel; Manfred Steiner; Ulrich Freitag; Tobias Gilster; Alexander Schmittel; Michael Friedrich; Heidemarie Haase; Marion Gebhardt; Ludwig Kiesel; Michael Reinhardt; Michael Kreißl; Marianne Kloke; Lars-Christian Horn; Regina Wiedemann; Simone Marnitz; Anne Letsch; Isabella Zraik; Bernhard Mangold; Jochen Möckel; Céline Alt; Pauline Wimberger; Peter Hillemanns; Kerstin Paradies; Alexander Mustea; Dominik Denschlag; Ulla Henscher; Reina Tholen; Simone Wesselmann; Matthias W Beckmann
Journal:  Geburtshilfe Frauenheilkd       Date:  2022-02-11       Impact factor: 2.915

6.  Dose escalation in brachytherapy for cervical cancer: impact on (or increased need for) MRI-guided plan optimisation.

Authors:  A M Paton; K E Chalmers; H Coomber; A L Cameron
Journal:  Br J Radiol       Date:  2012-12       Impact factor: 3.039

7.  Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233.

Authors:  Mostafa Atri; Zheng Zhang; Helga Marques; Jeremy Gorelick; Mukesh Harisinghani; Aslam Sohaib; Dow-Mu Koh; Steven Raman; Michael Gee; Haesun Choi; Lisa Landrum; Robert Mannel; Linus Chuang; Jian Qin Michael Yu; Carolyn Kay McCourt; Michael Gold
Journal:  Eur J Radiol Open       Date:  2015

8.  Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer.

Authors:  Brandon M Barney; Ivy A Petersen; Sean C Dowdy; Jamie N Bakkum-Gamez; Kristi A Klein; Michael G Haddock
Journal:  Radiat Oncol       Date:  2013-04-08       Impact factor: 3.481

9.  Endoscopic findings of rectal mucosal damage after pelvic radiotherapy for cervical carcinoma: correlation of rectal mucosal damage with radiation dose and clinical symptoms.

Authors:  Tae Gyu Kim; Seung Jae Huh; Won Park
Journal:  Radiat Oncol J       Date:  2013-06-30

10.  A prospective observational study with dose volume parameters predicting rectosigmoidoscopic findings and late rectosigmoid bleeding in patients with uterine cervical cancer treated by definitive radiotherapy.

Authors:  Tae Hyun Kim; Joo-Young Kim; Dae Kyung Sohn; Yeon-Joo Kim; Yoon-Seok Lee; Sung Ho Moon; Sang Soo Kim; Dae Yong Kim
Journal:  Radiat Oncol       Date:  2013-01-31       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.